News IDEXX Laboratories, Inc.

Stocks

IDXX

US45168D1046

Medical Equipment, Supplies & Distribution

Real-time Estimate Cboe BZX Other stock markets 12:32:37 2026-07-14 EDT			5-day change	1st Jan Change
548.31 ^USD	-2.82%		-3.29%	-18.48%

07-13	Leerink Partners Adjusts IDEXX Laboratories Price Target to $715 From $725, Maintains Outperform Rating	MT
06-29	IDEXX Laboratories, Inc.(NasdaqGS:IDXX) added to Russell Midcap Value Benchmark	CI

All News

Mentions Relevance

07-13	Leerink Partners Adjusts IDEXX Laboratories Price Target to $715 From $725, Maintains Outperform Rating	MT
07-01	IDEXX Laboratories to Release 2026 Second Quarter Financial Results	BU
06-29	IDEXX Laboratories, Inc.(NasdaqGS:IDXX) added to Russell Midcap Value Benchmark	CI
06-29	IDEXX Laboratories, Inc.(NasdaqGS:IDXX) added to Russell 1000 Value Benchmark	CI
06-28	IDEXX Laboratories, Inc.(NasdaqGS:IDXX) added to Russell 3000E Value Benchmark	CI
06-28	IDEXX Laboratories, Inc.(NasdaqGS:IDXX) added to Russell 3000 Value Benchmark	CI
06-28	IDEXX Laboratories, Inc.(NasdaqGS:IDXX) added to Russell 1000 Value-Defensive Index	CI
06-28	IDEXX Laboratories, Inc.(NasdaqGS:IDXX) added to Russell 1000 Dynamic Index	CI
05-27	IDEXX Laboratories, Inc. Presents at Stifel Jaws & Paws Conference 2026, May-27-2026 10:55 AM
05-26	IDEXX Laboratories Expands Fecal Antigen Testing Platform With Tapeworm Detection	MT
05-26	IDEXX Laboratories Expands Fecal Dx Antigen Testing Platform With Taeniid Tapeworm Detection	CI
05-26	IDEXX Expands Fecal Dx Antigen Testing Platform with Taeniid Tapeworm Detection	BU
05-19	IDEXX SDMA Now Integrated into the Most Common Catalyst Chemistry Profiles	BU
05-19	Idexx Laboratories, Inc. Integrates Sdma into Catalyst Chemistry Profiles	CI
05-14	IDEXX Laboratories to Present at Stifel Conference and Announces 2026 Investor Day	BU
05-06	Rothschild & Co Redburn Adjusts Price Target on IDEXX Laboratories to $665 From $655	MT
05-06	Jefferies Adjusts Price Target on IDEXX Laboratories to $792 From $785	MT
05-05	IDEXX Laboratories : Quarterly Report for Quarter Ending March 31, 2026 (Form 10-Q)	PU
05-05	Tranche Update on IDEXX Laboratories, Inc.'s Equity Buyback Plan announced on August 13, 1999.	CI
05-05	IDEXX Laboratories, Inc., Q1 2026 Earnings Call, May 05, 2026
05-05	IDEXX Laboratories Q1 Comparable Earnings, Revenue Rise	MT
05-05	IDEXX Laboratories, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026	CI
05-05	IDEXX raises annual forecasts on strong pet diagnostics demand	RE
05-05	IDEXX Laboratories Q1 Comparable Earnings, Revenue Rise	MT
05-05	Earnings Flash (IDXX) IDEXX Laboratories Posts Q1 Comparable EPS $3.30, vs. FactSet Est of $3.39	MT